Startups
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders. The company is founded by renowned drug design and development scientist, J. Jean Cui, Ph.D., and biotech business veteran, Y. Peter Li, Ph.D., M.B.A. BlossomHill Therapeutics, Inc. is headquartered in San Diego, California.
Overview
Location
United States, California, San Diego
Employees
1-10
Total raised
$71M
Founded date
2020
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Vivo Capital | vivocapital.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 16, 2025 | BlossomHill Therapeutics Raises $84M in Series B Extension Funding | BlossomHill Therapeutics, Inc., a San Diego, CA-based clinical-stage biopharmaceutical company, raised $84M in Series B extension funding. The round was led by Janus Henderson Investors, Brahma Capital, and BioTrack Capital, and participati... |
| Feb 29, 2024 | With seeds from Turning Point, a new biotech blooms with $100M to take on small molecules | The first signs of spring are beginning to emerge and so too are the shoots of the next biotech from drug designer J. Jean Cui, Ph.D. BlossomHill Therapeutics has raised $100 million in a series B financing, bringing the company’s total fun... |
| Mar 4, 2021 | BlossomHill Therapeutics has raised a $71M Series A. The company focuses on oncology and autoimmune disorders. | |
| Mar 4, 2021 | BlossomHill Therapeutics Closes $71M Series A Financing | SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a biopharmaceutical company focusing on oncology and autoimmune disorders, announced today that the company raised $71 million in a Series A financing round. Corm... |
| Mar 4, 2021 | BlossomHill Therapeutics Inks $71M Series A | SAN DIEGO, CA, BlossomHill Therapeutics announced today that the company raised $71 million in a Series A financing round. >> Click here for more funding data on BlossomHill Therapeutics >> To export BlossomHill Therapeutics... |
| Mar 3, 2021 | BlossomHill Therapeutics Closes $71M Series A Financing | |
| BlossomHill Therapeutics | ||
| BlossomHill Therapeutics | “BlossomHill Therapeutics, Inc.” |
Reviews 0
FAQ about BlossomHill Therapeutics
When was BlossomHill Therapeutics founded?
BlossomHill Therapeutics was founded in 2020.
How much funding has BlossomHill Therapeutics raised?
BlossomHill Therapeutics has raised $71M in total across 1 funding round.
Who has invested in BlossomHill Therapeutics?
Parsers VC lists 2 investors of BlossomHill Therapeutics, among them Vivo Capital.
What has the press written about BlossomHill Therapeutics?
Parsers VC has collected 9 articles mentioning BlossomHill Therapeutics, among them “BlossomHill Therapeutics Raises $84M in Series B Extension Funding” (Dec 16, 2025) and “With seeds from Turning Point, a new biotech blooms with $100M to take on small molecules” (Feb 29, 2024).
Is BlossomHill Therapeutics still active?
Yes, BlossomHill Therapeutics is active; its latest activity on Parsers VC dates from Dec 19, 2025.